At the news
? BEARISHIMPACT 6/10 CLUSTER filed Feb 22, 2026 at 19:00 ET
Seven executives at KalVista Pharmaceuticals, including the CEO, CFO, CMO, CDO, and CCO, exercised stock options and sold shares in the open market over a 7-day period. The total value of shares sold was approximately $396,600, with all sales occurring at $15.5668 per share. The transactions appear to be part of a coordinated post-exercise selling activity following option exercises.
- CEO Palleiko sold 10,034 shares for $156,197; exercised 23,250 shares prior to sale
- All five C-suite executives exercised in-the-money stock options between Feb 21–23
- Total open-market sales: 25,477 shares sold for $396,600 across four days
- Sales were executed at a uniform price of $15.5668, indicating planned trades
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access